je.st
news
Bayer to Present Data on Multiple Oncology Compounds at the European...
2013-09-17 16:58:01| Chemicals - Topix.net
These data include an oral presentation of a subanalysis from the Phase III trial of sorafenib in patients with radioactive iodine-refractory differentiated thyroid cancer, an oral presentation and posters on the efficacy and safety of regorafenib, which was recently approved by the European Medicines Agency , and posters on additional analyses ... (more)
Tags: the
data
present
multiple
Category:Chemicals